Sensitivity and specificity of staging systems depending on eGFR in the derivation cohort
| . | Sensitivity (95% CI) . | P . | Specificity (95% CI) . | P . |
|---|---|---|---|---|
| All patients (n = 249) | ||||
| BU | 0.83 (0.78-0.88) | 1 | 0.63 (0.57-0.69) | .481 |
| Mayo | 0.82 (0.77-0.87) | 0.66 (0.60-0.72) | ||
| eGFR ≥ 30 mL/min/1.73 m2(n = 203) | ||||
| BU | 0.80 (0.75-0.86) | .688 | 0.70 (0.64-0.76) | .023 |
| Mayo | 0.78 (0.72-0.84) | 0.79 (0.73-0.84) | ||
| eGFR < 30 mL/min/1.73 m2(n = 46) | ||||
| BU | 0.95 (0.89-1) | 1 | 0.35 (0.21-0.48) | .063 |
| Mayo | 1 (1-1) | 0.15 (0.05-0.26) |
| . | Sensitivity (95% CI) . | P . | Specificity (95% CI) . | P . |
|---|---|---|---|---|
| All patients (n = 249) | ||||
| BU | 0.83 (0.78-0.88) | 1 | 0.63 (0.57-0.69) | .481 |
| Mayo | 0.82 (0.77-0.87) | 0.66 (0.60-0.72) | ||
| eGFR ≥ 30 mL/min/1.73 m2(n = 203) | ||||
| BU | 0.80 (0.75-0.86) | .688 | 0.70 (0.64-0.76) | .023 |
| Mayo | 0.78 (0.72-0.84) | 0.79 (0.73-0.84) | ||
| eGFR < 30 mL/min/1.73 m2(n = 46) | ||||
| BU | 0.95 (0.89-1) | 1 | 0.35 (0.21-0.48) | .063 |
| Mayo | 1 (1-1) | 0.15 (0.05-0.26) |